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The homotypic fusion of yeast vacuoles occurs in an ordered
cascade of priming, docking, and fusion. The linkage between
these steps has so far remained unclear. We now report that
Vam7p (the vacuolar SNAP-23y25 homolog) signals from the cis-
SNARE complex to Ypt7p (the vacuolar RabyYpt) to initiate the
docking process. After Vam7p has been released from the cis-
SNARE complex by Sec18p-mediated priming, it is still required for
Ypt7p-dependent docking and it needs Ypt7p to remain on the
vacuole. Thus, after priming, Vam7p is released from the vacuole
altogether if Ypt7p has been extracted by Gdi1p or inactivated by
antibody but is not released if docking is blocked simply by vacuole
dilution; it is therefore Ypt7p function, and not docking per se, that
retains Vam7p. In accord with this finding, cells deleted for the
gene encoding Ypt7 have normal amounts of Vam7p but have little
Vam7p on their isolated vacuoles. Interaction of Vam7p and Ypt7p
is further indicated by two-hybrid analysis [Uetz, P., Giot, L.,
Cagney, G., Mansfield, T. A., Judson, R. S., Knight, J. R., Lockshon,
D., Narayan, V., Srinivasan, M., Pochart, P., et al. (2000) Nature
(London) 403, 623–627] and by the effect of Vam7p on the asso-
ciation of the RabyYpt-effector HOPS complex (homotypic fusion
and vacuole protein sorting; Vam2p and Vam6p plus four vacuole
protein sorting class C proteins) with Ypt7p. Vam7p provides a
functional link between the priming step, which releases it from
the cis-SNARE complex, and docking.
Membrane trafficking requires a regulated cascade of vesiclebudding from the donor membrane and fusion with the
acceptor membrane (1, 2). Many proteins have been character-
ized that are essential for the fusion of vesicles with the target
membrane. Among these are the NEM-sensitive protein
(Sec18pyNSF) (3), soluble NSF attachment proteins (Sec17py
SNAPs) (4), a family of proteins termed SNAREs (5), GTPases
of the YptyRab family, and YptyRab effectors or tethering
factors (6, 7). SNAREs are initially found in cis complexes on
membranes (8–10) and are dissociated by NSF and a-SNAP (11)
before they function downstream in the docking reaction
through associations in trans (10, 12, 13). Tethering factors
together with Rab-proteins initiate the contact between the
membranes (8). Tethering can precede (14, 15) or follow (16, 17)
the dissociation of the cis-SNARE complex in the priming
reaction. Finally, several factors coordinate the fusion reaction.
SNAREs, calmodulin, synaptotagmin, and protein phosphatase
1 have all been implicated in this reaction stage (18–21).
Although RabyYpt proteins and their effectors regulate the
assembly of the trans-SNARE complex, we now report that the
YptyRab function can itself be regulated by a SNARE that has
been released from the cis-SNARE complex.
For the fusion of yeast vacuoles, the disassembly of the
preexisting cis-SNARE complex during priming is a prerequisite
for docking (16, 17). Part of this signaling from priming to
docking is performed by the homotypic fusion and vacuole
protein sorting (HOPS) complex (formerly called Vam2y6p
complex). The HOPS complex, which includes Vps11p, Vps16p,
Vps18p, Vps33p, Vps39pyVam6p, and Vps41pyVam2p (22–24,
36), is initially in association with SNAREs on isolated vacuoles
and is dissociated from the SNAREs during the priming reaction
(23). After priming, HOPS is recovered in a complex with the
GTP-form of Ypt7 (23, 36), defining it as a Rab effector complex
(6). Dilution of vacuoles during priming, or removal of Ypt7p by
Gdi1p, leads to a loss of the HOPS complex from the vacuole.
Furthermore, HOPS is essential for docking (22). Thus, HOPS
is one important element in signaling from priming to docking.
We now report that the Vam7p SNARE also signals between
priming and the Ypt7p-dependent stage of docking on the
vacuole fusion pathway.
Materials and Methods
Materials and Strains. All strains and reagents have been described
previously (13, 24–26).
Biochemical Methods. Vacuoles were isolated by spheroplasting in
the presence of oxalyticase, DEAE lysis, and Ficoll gradient
centrifugation (13). For each Vam7p release reaction, 30 mg of
vacuoles were incubated for the indicated times in the presence
of cytosol under fusion assay conditions (13), then chilled on ice,
diluted 5-fold with wash buffer (0.15 M KCly200 mM sorbitoly10
mM Pipes/KOH, pH 6.8), and centrifuged (10 min, 8,000 3 g,
4°C). The vacuole pellet was resuspended in 400 ml of wash
buffer and was centrifuged again. The proteins in the pooled
supernatant fraction were precipitated by addition of TCA to
13% (volyvol), incubated on ice for 10 min, centrifuged (10 min,
16,000 3 g, 4°C), and washed with ice-cold acetone. SDSyPAGE,
immunoblotting using ECL (27), and purification of IgGs (28)
were as described.
Results and Discussion
Wild-type vacuoles must be primed to undergo Ypt7p-
dependent docking (16, 17). Addition of antibody to Ypt7p or
the extraction of Ypt7p from the vacuole membrane by Gdi1p
does not affect priming (13). However, we find that Vam7p, the
SNAP-23y25 homolog on vacuoles (Fig. 1A, lane 1), is released
upon incubation with ATP and Gdi1p (Fig. 1 A, lane 3) and is
recovered in the reaction supernatant (Fig. 1 A, lane 3, bottom).
Vam7p was also released when antibodies to Ypt7p were added
(Fig. 1B, lane 8). Gdi1p mediated release (Fig. 1B, lane 4) is not
seen without ATP (lane 2) and is blocked by antibody to Sec17p,
Sec18p, or Vam3p (lanes 5–7), showing that it is strictly depen-
dent on priming. When docking is blocked by dilution (16),
Vam7p remains associated with the vacuoles (Fig. 1C, lane 3 vs.
lane 7). This shows that it is Ypt7p per se rather than docking
that is required to maintain the vacuole association of Vam7p.
We note that a portion of the Vam7p undergoes covalent
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modification to a form of slightly greater mobility (Fig. 1 A, lane
3; B, lane 3; and C, lane 1). This modification requires ATP (Fig.
1B, lane 2), priming (lanes 5–7), and vacuole contact (Fig. 1C,
lane 1 vs. lane 3). It can be reversed after priming by incubating
vacuoles with apyrase without loss of subsequent fusion (data
not shown); its molecular nature remains to be determined.
The need for Ypt7p to maintain the vacuole association of
Vam7p after priming presumably ref lects either a direct
Vam7p:Ypt7p interaction or an interaction of Vam7p with a
common element such as the HOPS complex. Although ypt7D
cells have a normal content of Vam7p, almost none of it is
localized to vacuoles (Fig. 2), showing that Ypt7p has a physi-
ological role in maintaining Vam7p on the vacuole. Indeed, a
recent two-hybrid analysis of protein-protein interactions of
yeast proteins identified Vam7p as an interaction partner of
Ypt7p (29). This concordance between the need for Vam7p for
docking (25), the demonstration of Vam7p:Ypt7p interaction by
two-hybrid analysis (29), the need for Ypt7p to keep Vam7p on
the vacuole (Fig. 2), and our biochemical studies (Fig. 1) that
show that Ypt7p only functions to anchor Vam7p after priming
has released Vam7p from the cis-SNARE complex (25) establish
this as a vital signaling event linking priming and docking.
Because both Vam7p (Fig. 2) and HOPS (23) require Ypt7p
to remain on the vacuole after incubation with ATP, we asked
whether these requirements might be related. Release of HOPS
by dilution was enhanced in vam7D vacuoles as compared with
the wild type (62% vs. 28%; Fig. 3, lane 4 vs. lane 8), whereas
release of the HOPS complex in vam3D and nyv1D vacuoles was
indistinguishable from the wild type (data not shown). These
data suggest that Vam7p and HOPS may interact with each other
as well as with Ypt7p. We conclude that Vam7p plays a central
role in signaling from priming to docking: (i) Vam7p is initially
essential for the integrity of cis-SNARE complexes (25), yet the
need for Vam7p function cannot be fulfilled before vacuole
docking (25). (ii) Sec18p is needed for Vam7p release, in vivo
(30) and in vitro (Fig. 1B). (iii) Ypt7p is only essential for Vam7p
to remain on the vacuole after priming has occurred (Fig. 1 A).
(iv) Although priming, which releases Vam7p from the cis-
SNARE complex (25), is required for tethering of wild-type
vacuoles (17), vacuoles without Vam3p, in which the Vam7p is
not in complex with other SNAREs (25), do not need priming
to tether (17). Conceivably, priming might only be needed for
tethering because it specifically releases Vam7p and HOPS (22,
23, 36). (v) Vam7p participates in stabilizing HOPS association
with the vacuole (Fig. 3).
Vam7p Regulates Docking Through Its Cycle of Associations. Al-
though most of the Vam7p is in a cis-complex with the SNAREs
on isolated vacuoles and is resistant to extraction by high pH
(25), priming releases Vam7p from the other SNAREs (25) and
its continued membrane association becomes more labile. Cell
fractionation has shown that a portion of Vam7p is normally
cytosolic, but the cytosolic Vam7p depends on functional Sec18p
(30), consistent with our finding that Vam7p release requires
priming (Fig. 1 A). Roche and coworkers (31) have demonstrated
a similar partitioning of SNAP-23 between the cytosol and the
membrane. Surprisingly, the final membrane attachment of
Fig. 1. Ypt7p is needed for the vacuole association of Vam7p after priming.
(A) Vam7p is released from the vacuole upon extraction of Ypt7p. BJ3505
vacuoles (30 mg) were incubated for 60 min at 27°C in the presence or absence
of Gdi1p and 0.5 mM Mg-ATP and an ATP regenerating system (13) where
indicated and were reisolated (4 min, 8,000 3 g, 4°C) as in Materials and
Methods. The pooled supernatant of reaction and wash and the reisolated
vacuoles were each mixed in sample buffer and were analyzed by SDSyPAGE
and immunoblotting. Immunoblots were decorated with antibodies to
Vam7p. (B) After priming, Ypt7p is required for Vam7p association with
vacuoles. BJ3505 vacuoles (30 mg) were incubated for 60 min at 27°C. Gdi1p or
antibodies to the indicated proteins were added to the reaction where
indicated. Proteins from the pellet fraction were analyzed by SDSyPAGE and
immunoblot with antibodies to Vam7p, Vti1p, and Ypt7p. (C) Vam7p release
is not triggered by dilution. Vacuoles (30 mg) were incubated in 150 ml (lanes
1, 2, 5, and 6) or 1.5 ml (lanes 3, 4, 7, and 8) as in A, and the pellet and
supernatant fractions were analyzed by immunoblot with antibodies to
Vam7p.
Fig. 2. Localization of Vam7p to the vacuoles depends on Ypt7p. Whole cell
extracts and vacuoles were prepared from BJ3505 wt, vam7D, and ypt7D
strains (25) and were analyzed by SDSyPAGE and immunoblotting with anti-
bodies to Vam7p and Vac8p.
Fig. 3. HOPS release is enhanced in vam7D vacuoles. BJ3505 wt or vam7D
vacuoles (12 mg) were incubated in reaction buffer for 90 min in the absence
or presence of ATP (24). Gdi1p (64 mgyml) was added where indicated. One
sample was incubated in a 20-fold diluted reaction volume. The reactions were
then diluted 5-fold with 10 mM PipesyKOH (pH 6.8) and 200 mM sorbitol, and
the vacuoles were sedimented by centrifugation (14,000 3 g, 5 min, 4°C).
Proteins in the supernatant were precipitated as described in Fig. 1 and were
analyzed by SDSyPAGE and immunoblotting with antibodies to Vam6p. Bands
were quantified by laser densitometry.
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SNAP-23 is regulated by a kinase, SNAK (31). Although we see
an ATP-dependent modification of Vam7p, we have not yet
established whether this is phosphorylation.
The partitioning of Vam7p between the cytosol and the
vacuole membrane may regulate vacuole fusion. Priming without
tethering would release Vam7p and thereby avoid an unproduc-
tive activation of Ypt7p. Guo et al. (32) have shown that the
SNAP-23 protein itself is relocated to the plasma membrane in
regulated secretion as a prerequisite for regulated exocytosis.
Some effector elements are thought to signal from Ypt7yRab
proteins to SNAREs. For example, Rab effectors interact phys-
ically with a syntaxin required for endosomal fusion (33), and the
yeast Rab effector Vac1 acts downstream of the Vps21 Rab
protein to regulate trans-SNARE complex assembly (34, 35). In
contrast, Vam7p is initially associated with SNAREs and only
associates with Ypt7p after it is released from this cis-SNARE
complex. Effectors like Vam7p that move from the cis-SNARE
complex to the Rab proteins may be distinct from those that
move from the Rabs to the trans-SNARE complex.
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